
ClearPoint Neuro CLPT
$ 9.44
0.21%
Annual report 2025
added 03-17-2026
ClearPoint Neuro Total Current Liabilities 2011-2026 | CLPT
Annual Total Current Liabilities ClearPoint Neuro
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.8 M | 10.4 M | 7.43 M | 6.79 M | 4.75 M | 3.2 M | 3.83 M | 2.01 M | 4.4 M | 3.02 M | 7.65 M | - | 10.1 M | 6.31 M | 14.6 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.6 M | 2.01 M | 6.8 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Orthofix Medical
OFIX
|
170 M | $ 11.78 | 0.51 % | $ 467 M | ||
|
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | ||
|
Delcath Systems
DCTH
|
11 M | $ 9.35 | 4.12 % | $ 335 M | ||
|
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | ||
|
Penumbra
PEN
|
183 M | $ 335.59 | 0.4 % | $ 13.1 B | ||
|
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | ||
|
Second Sight Medical Products
EYES
|
5.99 M | - | -0.97 % | $ 54.4 M | ||
|
Insulet Corporation
PODD
|
680 M | $ 221.0 | -2.0 % | $ 15.5 B | ||
|
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | ||
|
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | ||
|
IRadimed Corporation
IRMD
|
10.2 M | $ 101.26 | 0.29 % | $ 1.29 B | ||
|
AVITA Medical
RCEL
|
62.7 M | $ 3.96 | 3.13 % | $ 110 M | ||
|
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | ||
|
CONMED Corporation
CNMD
|
315 M | $ 36.45 | -0.37 % | $ 1.13 B | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | ||
|
Sintx Technologies
SINT
|
3.73 M | $ 2.6 | 1.17 % | $ 7.21 M | ||
|
NanoVibronix
NAOV
|
2.72 M | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
10.5 M | $ 24.7 | - | $ 209 M | ||
|
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | ||
|
MiMedx Group
MDXG
|
64.3 M | $ 4.11 | -0.61 % | $ 607 M | ||
|
Sensus Healthcare
SRTS
|
4.72 M | $ 4.18 | 5.43 % | $ 68.2 M | ||
|
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
9.82 M | $ 0.67 | -3.71 % | $ 36.5 M | ||
|
Aethlon Medical
AEMD
|
1.9 M | $ 2.31 | 6.94 % | $ 3.61 M | ||
|
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | ||
|
Stryker Corporation
SYK
|
7.79 B | $ 325.47 | -0.95 % | $ 124 B | ||
|
Tactile Systems Technology
TCMD
|
41 M | $ 27.52 | 2.46 % | $ 629 M | ||
|
InspireMD
NSPR
|
10.7 M | $ 1.79 | - | $ 115 M | ||
|
AdaptHealth Corp.
AHCO
|
712 M | $ 11.4 | -0.7 % | $ 1.54 B | ||
|
Myomo
MYO
|
8.35 M | $ 0.7 | 0.47 % | $ 29.3 M | ||
|
Tandem Diabetes Care
TNDM
|
243 M | $ 24.0 | -2.08 % | $ 1.63 B | ||
|
Nano-X Imaging Ltd.
NNOX
|
14 M | $ 2.34 | -2.71 % | $ 137 M | ||
|
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
37.8 M | $ 3.7 | -5.37 % | $ 138 M | ||
|
Quanterix Corporation
QTRX
|
74.8 M | $ 3.94 | 3.14 % | $ 168 M | ||
|
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 16.16 | 1.57 % | $ 379 M | ||
|
Outset Medical
OM
|
37.6 M | $ 3.48 | -1.42 % | $ 52.9 K |